Preventing the Abuse and Misuse of Over-the-Counter Medicines: A Survey of Community Pharmacists in Finland

References

• Abood, E. A., & Wazaify, M. (2016). Abuse and misuse of prescription and nonprescription drugs from community pharmacies in Aden City—Yemen. Substance Use & Misuse, 51(7), 942–947. https://doi.org/10.3109/10826084.2016.1155619
   PubMed Web of Science ®Google Scholar
• Al Mazrouei, N., Ibrahim, R. M., Al Meslamani, A. Z., Abdel-Qader, D. H., & Ibrahim, O. M. (2021). Virtual pharmacist interventions an abuse of over-the-counter-medications during COVID-19 versus traditional pharmacist interventions. Journal of the American Pharmacists Association, 61(3), 331–339. https://doi.org/10.1016/j.japh.2021.02.003
   PubMed Web of Science ®Google Scholar
• Albsoul-Younes, A. M., Jabateh, S. K., Abdel-Hafiz, S. M., & Al-Safi, S. A. (2004). Awareness and frequency of potential side effects on nonsteroidal anti-inflammatory drugs among the Jordanian patient population. Saudi Medical Journal, 25(7), 907–911. https://europepmc.org/article/med/15235698
   PubMed Web of Science ®Google Scholar
• Albsoul-Younes, A., Wazaify, M., Yousef, A. M., & Tahaineh, L. (2010). Abuse and misuse of prescription and nonprescrption drugs sold in community pharmacies in Jordan. Substance Use & Misuse, 45(9), 1319–1329. https://doi.org/10.3109/10826080802490683
   PubMed Web of Science ®Google Scholar
• Algarni, M., Hadi, M. A., Yahyouche, A., Mahmood, S., & Jalal, Z. (2021). A mixed-methods systematic review of the prevalence, reasons, associated harms and risk-reduction interventions of over-the counter (OTC) medicines misuse, abuse and dependence. Journal of Pharmaceutical Policy and Practice, 14(1), 1–16. https://doi.org/10.1186/s40545-021-00350-7
   PubMedGoogle Scholar
• Baker, E. H., & Sandle, G. I. (1996). Complications of laxative abuse. Annual Review of Medicine, 47, 127–134. https://doi.org/10.1146/annurev.med.47.1.127
   PubMed Web of Science ®Google Scholar
• Bassett, K. E., Schunk, J. E., & Crouch, B. I. (1996). Cyclizine abuse by teenagers in Utah. The American Journal of Emergency Medicine, 14(5), 472–474. https://doi.org/10.1016/S0735-6757(96)90156-4
   PubMed Web of Science ®Google Scholar
• Brennan, R., Wazaify, M., Shawabkeh, H., Boardley, I., McVeigh, J., & Van Hout, M. C. (2021). A Scoping review of non-medical and extra-medical use of non-steroidal anti-inflammatory drugs (NSAIDs). Drug Safety, 44(9), 917–928. https://doi.org/10.1007/s40264-021-01085-9
   PubMed Web of Science ®Google Scholar
• Cooper, R. J. (2013). Over-the-counter medicine abuse – a review of the literature. Journal of Substance Use, 18(2), 82–107. https://doi.org/10.3109/14659891.2011.615002
   PubMed Web of Science ®Google Scholar
• Fingleton, N. A., Watson, M. C., Duncan, E. M., & Matheson, C. (2016). Non-prescroption medicine misuse, abuse and dependence: A cross-sectional survey of the UK general population. Journal of Public Health (Oxford, England), 38(4), 722–730. https://doi.org/10.1093/pubmed/fdv204
   PubMed Web of Science ®Google Scholar
• Finnish Medicines Agency Fimea. (2015). National OTC medicines programme. Serial Publication Fimea Develops, Assesses and Informs 1/2015. ISBN 978-952-5624-51-9. https://www.fimea.fi/documents/160140/765540/28627_KAI_1_2015_EN.pdf
   Google Scholar
• Fleming, G. F., McElnay, J. C., & Hughes, C. M. (2004). Development of a community pharmacy-based model to identify and treat OTC drug abuse/misuse: A pilot study. Pharmacy World & Science, 26(5), 282–288. https://doi.org/10.1023/B:PHAR.0000042891.66983.60
   PubMedGoogle Scholar
• Gedeborg, R., Svennblad, B., Holm, L., Sjögren, H., Bardage, C., Personne, M., Sjöberg, G., Feltelius, N., & Zethelius, B. (2017). Increased availability of paracetamol in Sweden and incidence of paracetamol poisoning: Using laboratory data to increase validity of a polulation-based registry study. Pharmacoepidemiology and Drug Safety, 26(5), 518–527. https://doi.org/10.1002/pds.4166
   PubMed Web of Science ®Google Scholar
• Gott, P. H. (1968). Cyclizine toxicity—intentional drug abuse of a proprietary antihistamine. New England Journal of Medicine, 279(11), 596–596. https://doi.org/10.1056/NEJM196809122791109
   Web of Science ®Google Scholar
• Hämeen-Anttila, K., Mäntylä, A., Jyrkkä, J., & Enlund, H. (2014). Views of the Finnish public regarding over-the-counter medicines – availability, risks and access to information. Finnish Medicines Agency Fimea. Serial Publication Fimea Develops, Assesses and Informs 1/2014. ISBN 978-952-5624-40-3. https://www.julkari.fi/bitstream/handle/10024/130827/Väestön näkemyksiä itsehoitolääkkeistä.pdf
   Google Scholar
• Helisalmi, P., Tanskanen, P., Jyrkkä, J., & Vainio, K. (2017). Problems in self-medication - Analysis of cases documented by students during their internship in community pharmacies. Pharmaceutical Periodical Dosis, 33(1), 67–78. https://dosis.fi/wp-content/uploads/2018/03/Dosis_1_2017.pdf
   Google Scholar
• Helsingin Sanomat. (2021, November 17). Vaarallinen villitys leviää nuorten suosimassa Tiktokissa – kymmenissä videoissa ihannoidaan parasetamolin väärinkäyttöä. https://www.hs.fi/kotimaa/art-2000008338719.html
   Google Scholar
• Hughes, G. F., McElnay, J. C., Hughes, C. M., & McKenna, P. (1999). Abuse/misuse of non-prescription drugs. Pharmacy World & Science, 21(6), 251–255. https://doi.org/10.1023/A:1008788726842
   PubMedGoogle Scholar
• Kadam, P., & Bhalerao, S. (2010). Sample size calculation. International Journal of Ayurveda Research, 1(1), 55–57. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876926/
   PubMedGoogle Scholar
• Katz, K. D., Cannon, R. D., Cook, M. D., Amaducci, A., Day, R., Enyart, J., Burket, G., Porter, L., Roach, T., Janssen, J., & Williams, K. E. (2017). Loperamide-induced torsades de pointes: A case series. The Journal of Emergency Medicine, 53(3), 339–344. https://doi.org/10.1016/j.jemermed.2017.04.027
   PubMed Web of Science ®Google Scholar
• Lafferty, L., Hunter, T. S., & Marsh, W. A. (2006). Knowledge, attitudes and practices of pharmacists concerning prescription drug abuse. Journal of Psychoactive Drugs, 38(3), 229–232. https://doi.org/10.1080/02791072.2006.10399848
   PubMed Web of Science ®Google Scholar
• Lessenger, J. E., & Feinberg, S. D. (2008). Abuse of prescription and over-the-counter medications. Journal of the American Board of Family Medicine, 21(1), 45–54. https://doi.org/10.3122/jabfm.2008.01.070071
   PubMed Web of Science ®Google Scholar
• MacFadyen, L., Eadie, D., & McGowan, T. (2001). Community Pharmacists’ experience of over-the-counter medicine misuse in Scotland. The Journal of the Royal Society for the Promotion of Health, 121(3), 185–192. https://doi.org/10.1177/146642400112100316
   PubMedGoogle Scholar
• Madden, J. S., & Wilson, C. W. M. (1966). Deliberate aspirin intoxication. British Medical Journal, 1(5495), 1090–1090. https://doi.org/10.1136/bmj.1.5495.1090
   PubMedGoogle Scholar
• Major, C., & Vincze, Z. (2010). Consumer habits and interests regarding non-prescription medications in Hungary. Family Practice, 27(3), 333–338. https://doi.org/10.1093/fampra/cmp105
   PubMed Web of Science ®Google Scholar
• Manchikanti, L., Whitfield, E., & Pallone, F. (2005). Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): A public law for balancing treatment of pain and drug abuse and diversion. Pain Physician, 48(104), 335–347. https://pubmed.ncbi.nlm.nih.gov/16850056/
   Google Scholar
• Marraffa, J. M., Holland, M. G., Sullivan, R. W., Morgan, B. W., Oakes, J. A., Wiegand, T. J., & Hodgman, M. J. (2014). Cardiac conduction disturbance after loperamide abuse. Clinical Toxicology (Philadelphia, PA), 52(9), 952–957. https://doi.org/10.3109/15563650.2014.969371
   PubMed Web of Science ®Google Scholar
• Miller, H., Panahi, L., Tapia, D., Tran, A., & Bowman, J. D. (2017). Loperamide misuse and abuse. Journal of the American Pharmacists Association, 57(2S), S45–S50. https://doi.org/10.1016/j.japh.2016.12.079
   PubMedGoogle Scholar
• Ministry of Social Affairs and Health. (2018). Rational pharmacotherapy action plan, final report. Reports and memorandums of the ministry of social affairs and health 19/2018. http://urn.fi/URN:ISBN:978-952-00-3930-1
   Google Scholar
• Ohieku, J. D., & Jasini, T. S. (2015). Non-steroidal anti-inflammatory drugs misuse among newly diagnosed and resurged peptic ulcer patients in Maiduguri-city, Nigeria. Journal of Advances in Medical and Pharmaceutical Sciences, 4(3), 1–10. https://doi.org/10.9734/JAMPS/2015/19213
   Google Scholar
• Orriols, L., Gaillard, J., Lapeyre-Mestre, M., & Roussin, A. (2009). Evaluation of abuse and dependence on drugs used for self-medication. Drug Safety, 32(10), 859–873. https://doi.org/10.2165/11316590-000000000-00000
   PubMed Web of Science ®Google Scholar
• Patil, S., Subramany, S., Patil, S., Gurram, P., Singh, M., & Krause, M. (2018). Ibuprofen abuse—a case of rhabdomyolysis, hypokalemia, and hypophosphatemia with drug-induced mixed renal tubular acidosis. Kidney International Reports, 3(5), 1237–1238. https://doi.org/10.1016/j.ekir.2018.05.014
   PubMed Web of Science ®Google Scholar
• Powell, J. W., & Presnell, S. E. (2019). Loperamide as a potential drug of abuse and misuse: Fatal overdoses at the Medical University of South Carolina. Journal of Forensic Sciences, 64(6), 1726–1730. https://doi.org/10.1111/1556-4029.14115
   PubMed Web of Science ®Google Scholar
• Rasla, S., St Amand, A., Garas, M. K., El Melicy, A., & Minami, T. (2017). Unexpected serius cardiac arrhythmias in the setting of loperamide abuse. Rhode Island Medical Journal, 100(4), 33–36. http://rimed.org/rimedicaljournal/2017/04/2017-04-33-case-rasla.pdf
   Google Scholar
• Roumie, C. L., & Griffin, M. R. (2004). Over-the-counter analgesics in older adults: A call for improved labelling and consumer education. Drugs & Aging, 21(8), 485–498. https://doi.org/10.2165/00002512-200421080-00001
   PubMed Web of Science ®Google Scholar
• Rowe, C., Verjee, Z., & Koren, G. (1997). Adolescence dimenhydrinate abuse: Resurgence of an old problem. The Journal of Adolescent Health, 21(1), 47–49. https://doi.org/10.1016/S1054-139X(96)00291-1
   PubMed Web of Science ®Google Scholar
• Rutter, P. (2015). Role of community pharmacists in patients’ self-care and self-medication. Integrated Pharmacy Research & Practice, 4, 57–65. https://doi.org/10.2147/IPRP.S70403
   PubMedGoogle Scholar
• Sansgiry, S. S., Bhansali, A. H., Bapat, S. S., & Xu, Q. (2017). Abuse of over-the-counter medicines: A pharmacist’s perspective. Integrated Pharmacy Research & Practice, 6, 1–6. https://doi.org/10.2147/IPRP.S103494
   PubMed Web of Science ®Google Scholar
• Schifano, F., Chiappini, S., Miuli, A., Mosca, A., Santovito, M. C., Corkery, J. M., Guirguis, A., Pettorruso, M., Di Giannantonio, M., & Martinotti, G. (2021). Focus on over-the-counter drugs’ misuse: A systematic review on antihistamines, cough medicines, and decongestants. Frontiers in Psychiatry, 12(657397), 657397. https://doi.org/10.3389/fpsyt.2021.657397
   PubMedGoogle Scholar
• Sexton, J. D., & Pronchik, D. J. (1997). Diphenhydramine-induced psychosis with therapeutic doses. The American Journal of Emergency Medicine, 15(5), 548–549.https://doi.org/10.1016/s0735-6757(97)90212-6
   PubMed Web of Science ®Google Scholar
• Sihvo, S., Klaukka, T., Martikainen, J., & Hemminki, E. (2000). Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population. European Journal of Clinical Pharmacology, 56(6-7), 495–499. https://doi.org/10.1007/s002280000145
   PubMed Web of Science ®Google Scholar
• Sobczak, Ł., & Goryński, K. (2020). Pharmacological aspects of over-the-counter opioid drugs misuse. Molecules (Basel, Switzerland), 25(17), 3905. https://doi.org/10.3390/molecules25173905
   PubMed Web of Science ®Google Scholar
• SurveyMonkey Inc. (2022). Sample size calculator. San Mateo, CA. https://www.surveymonkey.com/mp/sample-size-calculator/.
   Google Scholar
• Svensk Farmaci. (2015, April 29). LV-besked om paracetamol välkomnas. https://www.svenskfarmaci.se/2015/04/29/lv-besked-valkomnas/
   Google Scholar
• The Association of Finnish Pharmacies. (2017, December 21). Fatalities related to abuse of loperamide have increased in Sweden. https://www.apteekkari.fi/uutiset/ripulilaakkeen-vaarinkayttoon-liittyvat-kuolemat-lisaantyneet-ruotsissa.
   Google Scholar
• The Association of Finnish Pharmacies. (2021, March). Annual review 2020. https://www.apteekkariliitto.fi/media/3-apteekkariliitto.fi/liitto/vuosikatsaukset/annual_review_2020_final.pdf.
   Google Scholar
• The Finnish Broadcasting Company (Yle). (2018, January 14). Finnish pharmacies list misused over-the-counter medicines. Report of The Association of Finnish Pharmacies, 1/2018. https://yle.fi/news/3-10022291.
   Google Scholar
• The Finnish Medical Society Duodecim. (2023). Self-medication. Current care guidelines. Working group appointed by the Finnish Medical Society Duodecim, Association of Finnish Pharmacies. https://www.kaypahoito.fi/hoi50106
   Google Scholar
• Vakkalanka, J. P., Charlton, N. P., & Holstege, C. P. (2017). Epidemiologic trends in loperamide abuse and misuse. Annals of Emergency Medicine, 69(1), 73–78. https://doi.org/10.1016/j.annemergmed.2016.08.444
   PubMed Web of Science ®Google Scholar
• Wastesson, J. W., Martikainen, J. E., Zoëga, H., Schmidt, M., Karlstad, Ø., & Pottegård, A. (2018). Trends in use of paracetamol in Nordic countries. Basic & Clinical Pharmacology & Toxicology, 123(3), 301–307. https://doi.org/10.1111/bcpt.13003
   PubMed Web of Science ®Google Scholar
• Wazaify, M., Abood, E., Tahaineh, L., & Albsoul-Younes, A. (2017). Jordanian community pharmacists’ experience regarding prescription and nonprescription drug abuse and misuse in Jordan – An update. Journal of Substance Use, 22(5), 463–468. https://doi.org/10.1080/14659891.2016.1235734
   Web of Science ®Google Scholar
• Wazaify, M., Hughes, C. M., & McElnay, J. C. (2006). The implementation of a harm minimisation model for the identification and treatment of over-the-counter drug misuse and abuse in community pharmacies in Northern Ireland. Patient Education and Counseling, 64(1–3), 136–141. https://doi.org/10.1016/j.pec.2005.12.008
   PubMed Web of Science ®Google Scholar
• Wazaify, M., Shields, E., Hughes, C. M., & McElnay, J. C. (2005). Societal perspectives on over-the-counter (OTC) medicines. Family Practice, 22(2), 170–176. https://doi.org/10.1093/fampra/cmh723
   PubMed Web of Science ®Google Scholar
• Williams, R. A. (2018). What patients don’t know about NSAIDs may lead to misuse. Pharm Today, 24(5), 34. https://doi.org/10.1016/j.ptdy.2018.04.020
   Google Scholar
• Wills, S. (2005). Over-the-Counter products. In Wills S (2nd ed.). Drugs of Abuse. London: The Pharmaceutical Press; 2005. 240–269. ISBN 978-0853695820.
   Google Scholar
• Wolf, B., Guarino, J. J., Preston, K. L., & Griffiths, R. R. (1989). Abuse liability of diphenhydramine in sedative abusers. NIDA Res Monogr, 95, 486–487. http://54.209.185.61/sites/default/files/monograph95.pdf
   PubMedGoogle Scholar
• World Health Organization. (1998). The Role of the pharmacist in self-care and self-medication: Report of the 4th WHO Consultative Group on the Role of the Pharmacist. The Hague, The Netherlands, 26–28 August 1998. https://apps.who.int/iris/handle/10665/65860
   Google Scholar
• World Health Organization. (2009). Regional Office for South-East Asia. Self-care in the context of primary health care. WHO Regional Office for South-East Asia. https://apps.who.int/iris/handle/10665/206352
   Google Scholar
• Wright, J., Bond, C., Robertson, H. D., & Matheson, C. (2016). Changes in over-the-counter drug misuse over 20 years: Perceptions from Scottish pharmacists. Journal of Public Health (Oxford, England), 38(4), 793–799. https://doi.org/10.1093/pubmed/fdv169
   PubMed Web of Science ®Google Scholar